March 16, 2026
We are proud to share that the article describing our chemiluminescent-based microfluidic thrombin generation assay (TGAlum) has been published at the Journal of Thrombosis and Haemostasis!
The study presents a proof of concept for the developed microfluidic assay and demonstrates its sensitivity to FVIII- and FIX-deficiencies in plasma as well as to DOAC treatment. Importantly, TGAlum shows a high level of agreement with standard TGA platforms, enabling further development toward a near-patient testing platform.
🔗 Read the full article here.
Enzyre is always looking for collaborations to expand use of its platform technologies. Interested parties are encouraged to contact us at info@enzyre.com.
Get involved